Eton Pharmaceuticals, Inc. (ETON)

Eton Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	14.94	21.39	16.31	14.41	21.3
Cash & Short-Term Investments	14.94	21.39	16.31	14.41	21.3
Cash Growth	-30.17%	31.17%	13.18%	-32.35%	76.49%
Receivables	5.36	3.41	1.85	5.47	0.05
Inventory	15.23	0.91	0.56	0.55	1.24
Prepaid Expenses	5.49	1.13	1.29	3.18	2.12
Total Current Assets	41.02	26.84	20	23.6	24.7
Property, Plant & Equipment	0.21	0.15	0.26	0.22	1
Other Intangible Assets	34.88	4.74	4.75	3.62	0.58
Other Long-Term Assets	0.01	0.01	0.01	0.02	0.04
Total Assets	76.12	31.74	25.03	27.47	26.32
Accounts Payable	4.17	1.85	1.77	1.77	2.34
Accrued Expenses	15.7	8.96	3.66	1.37	1.17
Current Portion of Long-Term Debt	-	5.38	1.03	1.42	0.28
Current Portion of Leases	0.08	0.05	-	-	-
Total Current Liabilities	19.95	16.24	6.46	4.56	3.79
Long-Term Debt	29.81	-	5.38	5.26	6.76
Long-Term Leases	0.11	0.02	0.11	0.02	0.1
Other Long-Term Liabilities	1.83	-	-	-	-
Total Liabilities	51.7	16.26	11.95	9.84	10.66
Common Stock	0.03	0.03	0.03	0.03	0.02
Additional Paid-In Capital	132.29	119.52	116.19	111.72	107.8
Retained Earnings	-107.89	-104.07	-103.13	-94.11	-92.16
Total Common Equity	24.43	15.48	13.08	17.63	15.66
Shareholders' Equity	24.43	15.48	13.08	17.63	15.66
Total Liabilities & Equity	76.12	31.74	25.03	27.47	26.32
Total Debt	29.99	5.46	6.52	6.7	7.14
Net Cash (Debt)	-15.06	15.93	9.78	7.71	14.15
Net Cash Growth	-	62.90%	26.85%	-45.52%	88.53%
Net Cash Per Share	-0.58	0.62	0.39	0.31	0.67
Filing Date Shares Outstanding	26.82	25.69	25.46	24.63	24.41
Total Common Shares Outstanding	26.71	25.69	25.35	24.63	24.31
Working Capital	21.07	10.6	13.54	19.05	20.91
Book Value Per Share	0.91	0.60	0.52	0.72	0.64
Tangible Book Value	-10.45	10.74	8.32	14.01	15.09
Tangible Book Value Per Share	-0.39	0.42	0.33	0.57	0.62
Machinery	0.38	0.35	0.34	0.4	1.32
Construction In Progress	-	-	0.01	-	-
Leasehold Improvements	0.1	0.1	0.07	0.07	0.18

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q